Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 28, 2015; 21(36): 10435-10442
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10435
Table 1 Demographic distribution of the subjects receiving different eradication regimens
CharacteristicHybrid therapy (n = 88)Sequential therapy (n = 87)P value
Age (mean ± SD), yr52.1 ± 13.054.6 ± 13.20.26
Gender (male/female)39/4925/620.04
Smoking1460.10
Alcohol consumption20180.74
Ingestion of coffee61570.59
NSAID user880.96
Underlying diseases26230.77
Endoscopic finding (Peptic ulcer/non-ulcer dyspepsia)46/4232/550.06
Helicobacter pylori density (mild/moderate/marked)8/42/384/57/260.26